The Roche Group owns the entire shares of Genentech in the USA and the majority shares of Chugai Pharmaceutical in Japan.
Encouraging scientific approaches and adapting innovative ideas, Roche, as a research-oriented company, utilizes the latest technologies and discoveries while developing its products. By investing 14 billion Swiss francs in R&D in 2022, Roche is among the top 9 investors in R&D among all industries and ranks 1st in health R&D.
Roche has been named one of the most sustainable companies in the pharmaceutical industry by the Dow Jones Sustainability Indices for the 14th time in a row, based on the long-term perspective it adopts in its fields of activity. This is a result of Roche's efforts to increase access to healthcare in every country where it operates, with local collaborations.
In addition, more than 30 medicines developed by Roche, including life-saving antibiotics, antimalarials and cancer drugs, are on the World Health Organization's Model List of Essential Medicines.
Launched in 1958, Roche Pharmaceuticals has been providing treatment solutions to Turkish physicians and patients with more than 250 employees and innovative products. Since 2015, it has been conducting its operations from its head office in Maslak-Uniq, Istanbul.
With the innovative solutions it provides, Roche Diagnostics enables patients to benefit more from their treatment processes with the vision of innovating diagnostics, shaping healthcare and changing lives. It improves patients' lives with its innovative and advanced technology-based devices for professional and personal use, biochemistry, hormone, genetic, molecular and cancer testing portfolio in the fields of Centralised & Point-of-Care Solutions, Molecular Solutions and Diabetes Care.
Operating in Turkey since 1991, Roche Diagnostics carries out its activities from its head office in Istanbul Metro City with more than 250 employees.
Banu Gülsün - People and Culture Leader
Gizem Özbayraç - Business, Agility, Digital and Data Leader
Dr. Mahir Kurt - Medical Leader
Omar Kamal - Finance and IT Leader
Dicle Gündoğdu - Legal and Sustainability Leader
Umut Bal - Marketing and Customer Engagement Leader
Ceylan Karslı - Legal and Compliance Chapter Head
Doğutan Ülgen - Healthcare Solutions Development Chapter Head
Doruk Örs - Finance and Operations Chapter Head
Duygu Karakaş - People and Culture Chapter Head
Kamil Pir - Marketing Chapter Head
Volkan Girgin - Commercial and Professional Services Chapter Head
Hasan Demirci - Head of Central Asia & Caucasian Countries
Zeynep Duru Halazaoğlu - Diabetes Care Türkiye Country Manager
The information provided on this site is not for diagnostic or medical advice, but for informational purposes. If you have or think you have a disease to be treated, consult a specialist physician.
For adverse events related to Roche products,
To contact us about other issues;
Roche Pharma Address: Roche Müstahzarları San A.Ş. Uniq İstanbul Ayazağa Caddesi No:4D/101 34396 Maslak/İstanbul Tel: +90 212 366 90 00
Roche Diagnostics Address: Roche Diagnostics Turkey A.Ş. Esentepe Mah. Kırgülü Sk. Metrocity İş Merkezi D Bl. No: 4/5 34394 Şişli /İstanbul; Tel: +90 212 306 06 06
Supervisor: Bahar Süral